Advertisement

< Back to Article

The Economics of Reproducibility in Preclinical Research

Fig 2

Estimated US preclinical research spend and categories of errors that contribute to irreproducibility.

Note that the percentage value of error for each category is the midpoint of the high and low prevalence estimates for that category divided (weighted) by the sum of all midpoint error rates (see S1 Dataset). Source: Chakma et al. [18] and the American Association for the Advancement of Science (AAAS) [19].

Fig 2

doi: https://doi.org/10.1371/journal.pbio.1002165.g002